Diabetes and the WHO Model List of Essential Medicines
- PMID: 34919863
- DOI: 10.1016/S2213-8587(21)00318-1
Diabetes and the WHO Model List of Essential Medicines
Conflict of interest statement
FNK declares no competing interests. IBH receives research funding from Medtronic Diabetes, Insulet, and Beta Bionics. IBH receives consulting fees from Abbott Diabetes Care, Roche, Bigfoot, and GWave.
Comment in
-
Diabetes and the WHO Model List of Essential Medicines.Lancet Diabetes Endocrinol. 2022 Jan;10(1):17-18. doi: 10.1016/S2213-8587(21)00323-5. Lancet Diabetes Endocrinol. 2022. PMID: 34919864 No abstract available.
-
Diabetes and the WHO Model List of Essential Medicines.Lancet Diabetes Endocrinol. 2022 Jan;10(1):18-19. doi: 10.1016/S2213-8587(21)00322-3. Lancet Diabetes Endocrinol. 2022. PMID: 34919865 No abstract available.
-
Diabetes and the WHO Model List of Essential Medicines.Lancet Diabetes Endocrinol. 2022 Jan;10(1):19-20. doi: 10.1016/S2213-8587(21)00321-1. Lancet Diabetes Endocrinol. 2022. PMID: 34919866 No abstract available.
-
Diabetes and the WHO Model List of Essential Medicines.Lancet Diabetes Endocrinol. 2022 Jan;10(1):20-21. doi: 10.1016/S2213-8587(21)00320-X. Lancet Diabetes Endocrinol. 2022. PMID: 34919867 No abstract available.
Comment on
-
Diabetes and the WHO Model List of Essential Medicines.Lancet Diabetes Endocrinol. 2022 Jan;10(1):21. doi: 10.1016/S2213-8587(21)00317-X. Lancet Diabetes Endocrinol. 2022. PMID: 34919868 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
